Combined Treatment of Pancreatic Cancer with Mithramycin A and Tolfenamic Acid Promotes Sp1 Degradation and Synergistic Antitumor Activity

Title
Combined Treatment of Pancreatic Cancer with Mithramycin A and Tolfenamic Acid Promotes Sp1 Degradation and Synergistic Antitumor Activity
Authors
Keywords
-
Journal
CANCER RESEARCH
Volume 70, Issue 3, Pages 1111-1119
Publisher
American Association for Cancer Research (AACR)
Online
2010-01-20
DOI
10.1158/0008-5472.can-09-3282

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now